The tension between profit and patient care is perhaps the most enduring conflict in modern medicine. For decades, the narrative has been framed as a zero-sum game: any dollar diverted toward an investor’s return is a dollar stolen from a patient’s bedside. This perception is particularly acute in behavioral health, where the vulnerability of the population makes the introduction of private equity (PE) feel, to many, like a fundamental breach of ethics.
However, as a physician and journalist, I have found that the reality of healthcare delivery is rarely so binary. While the risks of “strip-and-flip” investment strategies are real, there is a compelling counter-argument: that without significant infusions of private capital, many essential services—particularly high-infrastructure psychiatric care—would simply cease to exist or never be built in the first place.
The debate is no longer just about who owns the hospital, but about how the system incentivizes care. When we examine the intersection of private equity and patient care, the real question isn’t whether profit and healing can coexist, but whether our current reimbursement models reward the quality of the outcome or the volume of the service.
To explore this, we can glance at the perspective of leaders like Steve Page, Founder and CEO of SUN Behavioral Health. Page operates at the center of this controversy, leading a private-equity-backed organization that develops psychiatric hospitals. His experience suggests that capital is not the enemy—misaligned incentives are.
The Capital Gap: Why Private Equity Enters Behavioral Health
Psychiatric hospitals are among the most expensive healthcare facilities to develop. Unlike a standard outpatient clinic, these facilities require specialized architecture for patient safety, rigorous compliance with state and federal regulations, and a high ratio of trained staff to patients. For many communities, the “mental health bed shortage” is a crisis that government funding and philanthropy have failed to solve.
Private equity fills this void by providing the substantial upfront capital and the long-term financial runway required to bring these facilities to market. In the case of SUN Behavioral Health, the organization’s mission—”Solving Unmet Needs”—is predicated on the idea that the market cannot provide these services without a sustainable business model. When government agencies are unable or unwilling to fund the startup costs of a new psychiatric facility, private investment becomes the only viable path to expanding access to care.
This is not without risk. The primary criticism of PE in healthcare is the tendency toward short-term profit maximization, often achieved through aggressive cost-cutting or excessive leverage. When a firm is over-leveraged, a slight dip in reimbursement rates or a shift in policy can lead to staffing shortages or reduced services. Yet, the alternative in many regions is not a well-funded public hospital, but a complete absence of acute behavioral health beds, forcing patients into emergency rooms or jails.
The “Arms Race” and Misaligned Incentives
One of the most critical insights into the inefficiency of the current system is the “arms race” for commercially insured patients. In the United States, many hospitals—regardless of whether they are for-profit or nonprofit—experience a financial squeeze. They often lose money on Medicaid and Medicare patients and must make up those margins through patients with private commercial insurance.
This creates a perverse incentive. To attract the most profitable patients, hospitals often invest in “amenities” rather than clinical outcomes. We see the rise of luxury lobbies, private suites, and high-end facilities that look more like hotels than hospitals. While these features may attract commercial payers, there is little evidence-based data to suggest that a crackling fireplace in the lobby improves the clinical recovery of a patient in a psychiatric crisis.
This systemic flaw is a result of a “fee-for-service” model, where providers are paid based on the volume of services rendered rather than the health of the population. This is why there is a global push toward value-based care models, which aim to reward providers for quality, efficiency, and long-term patient wellness rather than the number of tests ordered or days spent in a bed.
The Clinical Firewall: Who Actually Makes the Decisions?
A common fear is that a private equity partner in a boardroom will dictate the length of a patient’s stay to maximize profit. However, in practice, there is a strong “clinical firewall” that protects patient care. Admission and discharge decisions are made by licensed physicians and clinicians, not by investors. These professionals operate under strict regulatory frameworks and hold professional licenses that would be jeopardized if they prioritized profit over patient safety.
The role of the investor is generally focused on governance, compliance, and operational efficiency. In many cases, PE firms actually strengthen clinical integrity by implementing more rigorous oversight and risk management structures than those found in smaller, independent facilities. By demanding standardized compliance and evidence-based protocols, these investors can reduce the variance in care quality across multiple sites.
the people delivering the care—the nurses, therapists, and physicians—are typically driven by a vocational commitment to patient wellbeing. Whether they work for a government-run clinic or a PE-backed hospital, their primary motivation remains the recovery of the person in front of them. The real threat to this integrity is not the ownership structure, but the lack of resources—such as understaffing or burnout—which can occur in any ownership model that fails to maintain a healthy margin.
Scale, Safety, and the Freestanding Model
In behavioral health, the size and structure of a facility can directly impact patient safety. There is a notable difference between a psychiatric unit located within a general medical hospital and a freestanding psychiatric hospital.
Freestanding facilities often operate at a larger scale, which allows for several advantages:
- Specialized Staffing: Larger facilities can employ more staff specifically trained in behavioral health de-escalation, reducing the reliance on seclusion, and restraints.
- Environmental Design: They can dedicate more space for patients to decompress, which is critical for reducing acuity and preventing incidents.
- Resource Concentration: Scale allows for the integration of more diverse therapeutic offerings and a more robust support system for frontline caregivers.
While the “for-profit” label often attracts negative headlines, the scale provided by private capital can paradoxically create a safer environment than the smaller, often under-resourced units found in general hospitals. This highlights the importance of focusing on the model of care rather than the label of ownership.
The Path Forward: Value over Volume
If we want to ensure that private equity and patient care coexist harmoniously, the focus must shift toward policy reform. The goal should be to move away from ownership-based debates and toward incentive-based solutions. Policymakers should prioritize the creation of reimbursement structures that reward “value”—defined as the improvement of population health and the reduction of the total cost of care.
For example, in behavioral health, the most “valuable” outcome is not a patient who is treated and then immediately relapses, but a patient who is stabilized and successfully transitioned into community-based support. When the system rewards long-term stability rather than short-term bed occupancy, the profit motive of a private equity firm aligns with the health goals of the patient.
we must address the broader determinants of health. As the U.S. Spends significantly more on healthcare per capita than other OECD nations—often spending significantly more than peer countries—the question is not how much we spend, but where we spend it. Integrating housing and food security into the healthcare continuum (the “housing is healthcare” model) can reduce the demand for expensive acute psychiatric interventions, creating a more sustainable system for all.
Key Takeaways for Healthcare Stakeholders
- Capital as an Enabler: Private equity provides the necessary infrastructure funding for psychiatric care that public and philanthropic sources often cannot meet.
- Incentives over Ownership: The “profits vs. Patients” conflict is often a symptom of a fee-for-service system that rewards volume over value.
- Clinical Autonomy: Professional licensing and regulatory frameworks act as a firewall, ensuring that clinicians—not investors—make treatment decisions.
- The Scale Advantage: Freestanding, larger-scale behavioral health facilities can offer safer environments through better staffing and specialized design.
- Policy Shift: The future of sustainable care lies in value-based reimbursement that rewards long-term patient outcomes.
The evolution of healthcare requires a sophisticated understanding of how capital, governance, and clinical practice intersect. While we must remain vigilant against the risks of predatory investment, we should not dismiss the role of private capital in solving some of our most pressing healthcare infrastructure gaps. By aligning financial incentives with clinical excellence, we can build a system where the pursuit of sustainability and the pursuit of healing are one and the same.
As we move toward the next cycle of healthcare reimbursement updates and policy reviews, the industry will likely see a continued push toward value-based metrics. The success of this transition will depend on whether we can move past the labels of “for-profit” and “nonprofit” to focus on the only metric that truly matters: the patient’s recovery.
Do you believe the ownership of a healthcare facility fundamentally changes the quality of care received? We invite you to share your professional experiences and perspectives in the comments below.